Enhanced inflammatory potential of CD4+ T-cells that lack proteasome immunosubunit expression, in a T-cell transfer-based colitis model

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Rasid, Orhan ^a   Meulenbroeks, Chantal ^a   Gröne, Andrea ^a   Zaiss, Dietmar ^a,b   Sijts, Alice ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; PROTEASOME; TUMOR NECROSIS FACTOR ALPHA; DEXTRAN SULFATE; HOMEODOMAIN PROTEIN; PROTEIN SUBUNIT; RAG-1 PROTEIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; EFFECTOR CELL; IMMUNE RESPONSE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE TRANSFER; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN MODIFICATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CHEMICALLY INDUCED; DISEASE MODEL; FEMALE; GENE DELETION; GENE EXPRESSION; GENETICS; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; MALE; PATHOLOGY; PROTEIN SUBUNIT; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; COLITIS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; FEMALE; GENE DELETION; GENE EXPRESSION; HOMEODOMAIN PROTEINS; INFLAMMATION; INTERLEUKIN-17; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN SUBUNITS;

EID: 84899678100     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095378     Document Type: Article

References (26)

1. Alkalay I, Yaron A, Hatzubai A, Orian A, Ciechanover A, et al. (1995) Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway. Proc Natl Acad Sci U S A 92: 10599-10603.
2. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T (1994) The ubiquitinproteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 78: 773-785.
3. Traenckner EB, Wilk S, Baeuerle PA (1994) A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. EMBO J 13: 5433-5441.
4. Sijts EJ, Kloetzel PM (2011) The role of the proteasome in the generation of MHC class I ligands and immune responses. Cell Mol Life Sci 68: 1491-1502.
5. Coux O, Tanaka K, Goldberg AL (1996) Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 65: 801-847.
6. Griffin TA, Nandi D, Cruz M, Fehling HJ, Kaer LV, et al. (1998) Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits. J Exp Med 187: 97-104.
7. Zaiss DM, de Graaf N, Sijts AJ (2008) The proteasome immunosubunit multicatalytic endopeptidase complex-like 1 is a T-cell-intrinsic factor influencing homeostatic expansion. Infect Immun 76: 1207-1213.
8. Kincaid EZ, Che JW, York I, Escobar H, Reyes-Vargas E, et al. (2012) Mice completely lacking immunoproteasomes show major changes in antigen presentation. Nat Immunol 13: 129-135.
9. Zaiss DM, Bekker CP, Grone A, Lie BA, Sijts AJ (2011) Proteasome immunosubunits protect against the development of CD8 T cell-mediated autoimmune diseases. J Immunol 187: 2302-2309.
10. Seifert U, Bialy LP, Ebstein F, Bech-Otschir D, Voigt A, et al. (2010) Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell 142: 613-624.
11. Pickering AM, Koop AL, Teoh CY, Ermak G, Grune T, et al. (2010) The immunoproteasome, the 20S proteasome and the PA28alphabeta proteasome regulator are oxidative-stress-adaptive proteolytic complexes. Biochem J 432: 585-594.
12. Hensley SE, Zanker D, Dolan BP, David A, Hickman HD, et al. (2010) Unexpected role for the immunoproteasome subunit LMP2 in antiviral humoral and innate immune responses. J Immunol 184: 4115-4122.
13. Qureshi N, Morrison DC, Reis J (2012) Proteasome protease mediated regulation of cytokine induction and inflammation. Biochim Biophys Acta 1823: 2087-2093.
14. Muchamuel T, Basler M, Aujay MA, Suzuki E, Kalim KW, et al. (2009) A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis. Nat Med 15: 781-787.
15. Schmidt N, Gonzalez E, Visekruna A, Kuhl AA, Loddenkemper C, et al. (2010) Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis. Gut 59: 896-906.
16. Basler M, Dajee M, Moll C, Groettrup M, Kirk CJ (2010) Prevention of experimental colitis by a selective inhibitor of the immunoproteasome. J Immunol 185: 634-641.
17. Kalim KW, Basler M, Kirk CJ, Groettrup M (2012) Immunoproteasome subunit LMP7 deficiency and inhibition suppresses Th1 and Th17 but enhances regulatory T cell differentiation. J Immunol 189: 4182-4193.
18. Powrie F, Leach MW, Mauze S, Menon S, Caddle LB, et al. (1994) Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1: 553-562.
19. Coombes JL, Robinson NJ, Maloy KJ, Uhlig HH, Powrie F (2005) Regulatory T cells and intestinal homeostasis. Immunol Rev 204: 184-194.
20. Zaiss DM, van Loosdregt J, Gorlani A, Bekker CP, Gröne A, et al. (2013) Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptor. Immunity 38: 275-284.
21. Visekruna A, Joeris T, Seidel D, Kroesen A, Loddenkemper C, et al. (2006) Proteasome-mediated degradation of IkappaBalpha and processing of p105 in Crohn disease and ulcerative colitis. J Clin Invest 116: 3195-3203.
22. Basler M, Mundt S, Muchamuel T, Moll C, Jiang J, et al. (2014) Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis. EMBO Mol Med 6: 226-238.
23. Dahlmann B, Ruppert T, Kloetzel PM, Kuehn L (2001) Subtypes of 20S proteasomes from skeletal muscle. Biochimie 83: 295-299.
24. Joeris T, Schmidt N, Ermert D, Krienke P, Visekruna A, at al. (2012) The proteasome system in infection: Impact of b5 and LMP7 on composition, maturation and quantity of active proteasome complexes. PLoS One.7(6): e39827. Doi:10.1371/journal.pone.0039827.
25. Caudill CM, Jayarapu K, Elenich L, Monaco JJ, Colbert RA, et al. (2006) T cells lacking immunoproteasome subunits MECL-1 and LMP7 hyperproliferate in response to polyclonal mitogens. J Immunol 176: 4075-82.
26. van Helden MJ, de Graaf N, Bekker CP, Boog CJ, Zaiss DM, et al. (2011) Immunoproteasome-deficiency has no effects on NK cell education, but confers lymphocytes into targets for NK cells in infected wild-type mice. PLoS One.6(8): e23769. doi:10.1371/journal.pone.0023769.